{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T13:54:14Z","timestamp":1789480454040,"version":"build-2803163510"},"reference-count":40,"publisher":"MDPI AG","issue":"9","license":[{"start":{"date-parts":[[2022,9,6]],"date-time":"2022-09-06T00:00:00Z","timestamp":1662422400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002803","name":"Fondazione Cariplo","doi-asserted-by":"publisher","award":["2020-1363"],"award-info":[{"award-number":["2020-1363"]}],"id":[{"id":"10.13039\/501100002803","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccines"],"abstract":"<jats:p>Background: An increasing number of cutaneous adverse reactions (CARs) to SARS-CoV-2 vaccines have been reported, but their incidence is debated. Objective: To estimate the pooled incidence of CARs to SARS-CoV-2 vaccines in the general adult population. Methods: A systematic review and meta-analysis of original articles published on MEDLINE via PubMed and Web Of Science from 1 January 2020 to 18 July 2022 was undertaken. Studies reporting the incidence proportion of CARs (defined as number of new cases of CARs on the total of vaccinated people) were included. All types of SARS-CoV-2 vaccine were included. People receiving at least one dose were considered eligible. Local cutaneous reactions were excluded. Results: A total of 970 records were identified and screened by title and abstract; 22 observational studies were included with aggregate data on 93,165 participants. The pooled incidence of overall CARs was 5% (95%CI 4\u20136%; I2 = 99%; p &lt; 0.001), ranging from &lt;0.01 to 19.00%. Most CARs were new onset dermatitis including rash, urticaria and vascular lesions; one case of Steven\u2013Johnson syndrome and six cases of erythema multiforme were reported. In the sensitivity analysis we found that the incidence of CARs after the first and second dose was similar, i.e., 3% (95%CI 2\u20133%; I2 = 96%; p &lt; 0.001) and 3% (95%CI 2\u20134%; I2 = 97%; p &lt; 0.001), respectively. The magnitude of incidence of CARs remained unchanged independently of vaccine platform and in the general population versus healthcare workers. Conclusions: CARs associated with SARS-CoV-2 vaccines are frequent but mild and self-remitting, whereas severe CARs are rare.<\/jats:p>","DOI":"10.3390\/vaccines10091475","type":"journal-article","created":{"date-parts":[[2022,9,8]],"date-time":"2022-09-08T20:50:27Z","timestamp":1662670227000},"page":"1475","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Cutaneous Adverse Reactions to SARS-CoV-2 Vaccines: A Systematic Review and Meta-Analysis"],"prefix":"10.3390","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6163-6921","authenticated-orcid":false,"given":"Francesco","family":"Bellinato","sequence":"first","affiliation":[{"name":"Section of Dermatology and Venereology, Department of Medicine, University of Verona, 37126 Verona, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7454-1999","authenticated-orcid":false,"given":"Zeno","family":"Fratton","sequence":"additional","affiliation":[{"name":"Section of Dermatology and Venereology, Department of Medicine, University of Verona, 37126 Verona, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8548-0493","authenticated-orcid":false,"given":"Giampiero","family":"Girolomoni","sequence":"additional","affiliation":[{"name":"Section of Dermatology and Venereology, Department of Medicine, University of Verona, 37126 Verona, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1777-9001","authenticated-orcid":false,"given":"Paolo","family":"Gisondi","sequence":"additional","affiliation":[{"name":"Section of Dermatology and Venereology, Department of Medicine, University of Verona, 37126 Verona, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,9,6]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1038\/d41586-020-03441-8","article-title":"The UK has approved a COVID vaccine-here\u2019s what scientists now want to know","volume":"588","author":"Ledford","year":"2020","journal-title":"Nature"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1056\/NEJMoa2034577","article-title":"Safety and efficacy of the BNT162b2 mRNA COVID-19 vaccine","volume":"383","author":"Polack","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"ref_3","unstructured":"(2022, August 01). Available online: https:\/\/www.ema.europa.eu\/en\/human-regulatory\/overview\/public-health-threats\/coronavirus-disease-covid-19\/treatments-vaccines\/vaccines-covid-19\/covid-19-vaccines-authorised."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"72683","DOI":"10.3389\/fimmu.2022.872683","article-title":"COVID-19 Vaccination and the Rate of Immune and Autoimmune Adverse Events Following Immunization: Insights from a Narrative Literature Review","volume":"13","author":"Mahroum","year":"2022","journal-title":"Front. Immunol."},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Moher, D., Liberati, A., Tetzlaff, J., Altman, D.G., and PRISMA Group (2009). Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement. PLoS Med., 6.","DOI":"10.1371\/journal.pmed.1000097"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1001\/jama.283.15.2008","article-title":"Meta-analysis of observational studies in epidemiology: A proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group","volume":"283","author":"Stroup","year":"2000","journal-title":"JAMA"},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Bellinato, F., Maurelli, M., Gisondi, P., and Girolomoni, G. (2021). Cutaneous Adverse Reactions Associated with SARS-CoV-2 Vaccines. J. Clin. Med., 10.","DOI":"10.3390\/jcm10225344"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1097\/XEB.0000000000000054","article-title":"Methodological guidance for systematic reviews of observational epidemiological studies reporting prevalence and cumulative incidence data","volume":"13","author":"Munn","year":"2015","journal-title":"Int. J. Evid.-Based Healthc. Sept."},{"key":"ref_9","unstructured":"(2022, August 01). Available online: https:\/\/jbi.global\/sites\/default\/files\/2019-05\/JBI_Critical_Appraisal-Checklist_for_Prevalence_Studies2017_0.pdf."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test","volume":"315","author":"Egger","year":"1997","journal-title":"BMJ"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.ijid.2021.07.052","article-title":"Safety and Reactogenicity of the ChAdOx1 (AZD1222) COVID-19 Vaccine in Saudi Arabia","volume":"110","author":"Albarrak","year":"2021","journal-title":"Int. J. Infect. Dis."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"101595","DOI":"10.1016\/j.pmedr.2021.101595","article-title":"Early solicited adverse events following the BNT162b2 mRNA vaccination, a population survey from Saudi Arabia","volume":"24","author":"Almohaya","year":"2021","journal-title":"Prev. Med. Rep."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"e619","DOI":"10.1111\/jdv.18150","article-title":"Cutaneous adverse effects of the available COVID-19 vaccines in India: A questionnaire-based study","volume":"36","author":"Bawane","year":"2022","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Bostan, E., Yel, B., and Karaduman, A. (2022). Cutaneous adverse events following 771 doses of the inactivated and mRNA COVID-19 vaccines: A survey study among health care providers. J. Cosmet. Dermatol.","DOI":"10.1111\/jocd.15203"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"e15452","DOI":"10.1111\/dth.15452","article-title":"Cutaneous adverse reactions to coronavirus vaccines: A Saudi nationwide study","volume":"35","author":"Bukhari","year":"2022","journal-title":"Dermatol. Ther."},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Cebeci Kahraman, F., Sava\u015f Erdo\u011fan, S., Akta\u015f, N.D., Albayrak, H., T\u00fcrkmen, D., Borlu, M., Ar\u0131ca, D.A., Demirba\u015f, A., Akbayrak, A., and Polat Ekinci, A. (2022). Cutaneous reactions after COVID-19 vaccination in Turkey: A multicenter study. J. Cosmet. Dermatol.","DOI":"10.1111\/jocd.15209"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"e402","DOI":"10.1111\/jdv.17951","article-title":"A study of COVID-19 vaccine (Covishield) induced dermatological adverse effects from India","volume":"36","author":"Das","year":"2022","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1111\/ced.14896","article-title":"Allergic and cutaneous reactions following inactivated SARS-CoV-2 vaccine (CoronaVac\u00ae) in healthcare workers","volume":"47","author":"Durmaz","year":"2022","journal-title":"Clin. Exp. Dermatol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"e548","DOI":"10.1111\/jdv.17343","article-title":"Cutaneous adverse reactions after m-RNA COVID-19 vaccine: Early reports from Northeast Italy","volume":"35","author":"Farinazzo","year":"2021","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"e15153","DOI":"10.1111\/dth.15153","article-title":"Cutaneous adverse reactions after COVID-19 vaccines in a cohort of 2740 Italian subjects: An observational study","volume":"34","author":"Grieco","year":"2021","journal-title":"Dermatol. Ther."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.3349\/ymj.2021.62.12.1162","article-title":"Adverse Events with the Pfizer-BioNTech COVID-19 Vaccine among Korean Healthcare Workers","volume":"62","author":"Im","year":"2021","journal-title":"Yonsei Med. J."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/j.jiac.2021.12.034","article-title":"Adverse reactions to the BNT162b2 and mRNA-1273 mRNA COVID-19 vaccines in Japan","volume":"28","author":"Kitagawa","year":"2022","journal-title":"J. Infect. Chemother."},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Klugar, M., Riad, A., Mekhemar, M., Conrad, J., Buchbender, M., Howaldt, H.P., and Attia, S. (2021). Side Effects of mRNA-Based and Viral Vector-Based COVID-19 Vaccines among German Healthcare Workers. Biology, 10.","DOI":"10.3390\/biology10080752"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"703","DOI":"10.47102\/annals-acadmedsg.2021160","article-title":"Safety and side effect profile of Pfizer-BioNTech COVID-19 vaccination among healthcare workers: A tertiary hospital experience in Singapore","volume":"50","author":"Lim","year":"2021","journal-title":"Ann. Acad. Med. Singap."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"e332","DOI":"10.1111\/jdv.17925","article-title":"Cutaneous reactions due to Pfizer\u2019s BNT162b2 mRNA and Moderna\u2019s mRNA-1273 vaccines","volume":"36","author":"Oulee","year":"2022","journal-title":"J. Eur. Acad. Dermatol Venereol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"e15223","DOI":"10.1111\/dth.15223","article-title":"Cutaneous adverse events related to COVID-19 vaccines: A cross-sectional questionnaire-based study of 867 patients","volume":"35","author":"Pourani","year":"2022","journal-title":"Dermatol. Ther."},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Riad, A., Pokorn\u00e1, A., Mekhemar, M., Conrad, J., Klugarov\u00e1, J., Ko\u0161\u010d\u00edk, M., Klugar, M., and Attia, S. (2021). Safety of ChAdOx1 nCoV-19 Vaccine: Independent Evidence from Two EU States. Vaccines, 9.","DOI":"10.3390\/vaccines9060673"},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Riad, A., Hockov\u00e1, B., Kantorov\u00e1, L., Sl\u00e1vik, R., Spurn\u00e1, L., Stebel, A., Havri\u013eak, M., and Klugar, M. (2021). Side Effects of mRNA-Based COVID-19 Vaccine: Nationwide Phase IV Study among Healthcare Workers in Slovakia. Pharmaceuticals, 14.","DOI":"10.3390\/ph14090873"},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Riad, A., Pokorn\u00e1, A., Klugarov\u00e1, J., Antalov\u00e1, N., Kantorov\u00e1, L., Ko\u0161\u010d\u00edk, M., and Klugar, M. (2021). Side Effects of mRNA-Based COVID-19 Vaccines among Young Adults (18-30 Years Old): An Independent Post-Marketing Study. Pharmaceuticals, 14.","DOI":"10.3390\/ph14101049"},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Riad, A., Pokorn\u00e1, A., Attia, S., Klugarov\u00e1, J., Ko\u0161\u010d\u00edk, M., and Klugar, M. (2021). Prevalence of COVID-19 Vaccine Side Effects among Healthcare Workers in the Czech Republic. J. Clin. Med., 10.","DOI":"10.3390\/jcm10071428"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1001\/jamadermatol.2021.2114","article-title":"Incidence of Cutaneous Reactions After Messenger RNA COVID-19 Vaccines","volume":"157","author":"Robinson","year":"2021","journal-title":"JAMA Dermatol."},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Ruiz-Villaverde, R., Rivera-Izquierdo, M., Gil-Villalba, A., Pegalajar-Garc\u00eda, M.D., P\u00e9rez-Rojas, J., Soler-Iborte, E., and Valero-Ubierna, M.C. (2022). Dermatological adverse reactions after vaccination with BNT162b2 in a cohort of healthcare workers. Int. J. Dermatol.","DOI":"10.1111\/ijd.16336"},{"key":"ref_33","unstructured":"(2022, August 01). Available online: https:\/\/cioms.ch\/publications\/product\/cioms-cumulative-pharmacovigilance-glossary\/."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"714170","DOI":"10.3389\/fimmu.2021.714170","article-title":"Efficacy, Immunogenicity and Safety of COVID-19 Vaccines: A Systematic Review and Meta-Analysis","volume":"12","author":"Sharif","year":"2021","journal-title":"Front. Immunol."},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Washrawirul, C., Triwatcharikorn, J., Phannajit, J., Ullman, M., Susantitaphong, P., and Rerknimitr, P. (2022). Global prevalence and clinical manifestations of cutaneous adverse reactions following COVID-19 vaccination: A systematic review and meta-analysis. J. Eur. Acad. Dermatol. Venereol.","DOI":"10.1111\/jdv.18294"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"6641","DOI":"10.1016\/j.vaccine.2015.09.026","article-title":"Vasculitis as an adverse event following immunization-Systematic literature review","volume":"34","author":"Bonetto","year":"2016","journal-title":"Vaccine"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"79","DOI":"10.2165\/00128071-200506020-00002","article-title":"Cutaneous adverse reactions following anti-infective vaccinations","volume":"6","author":"Nikkels","year":"2005","journal-title":"Am. J. Clin. Dermatol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.clindermatol.2014.12.009","article-title":"Cutaneous reactions to vaccinations","volume":"33","author":"Rosenblatt","year":"2015","journal-title":"Clin. Dermatol."},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Kounis, N.G., Koniari, I., de Gregorio, C., Velissaris, D., Petalas, K., Brinia, A., Assimakopoulos, S.F., Gogos, C., Kouni, S.N., and Kounis, G.N. (2021). Allergic reactions to current available COVID-19 vaccinations: Pathophysiology, causality, and therapeutic considerations. Vaccines, 9.","DOI":"10.3390\/vaccines9030221"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"e165","DOI":"10.1016\/j.jaad.2021.11.016","article-title":"Skin reactions to COVID-19 vaccines: An American Academy of Dermatology\/International League of Dermatological Societies registry update on reaction location and COVID vaccine type","volume":"86","author":"Freeman","year":"2022","journal-title":"J. Am. Acad. Dermatol."}],"container-title":["Vaccines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-393X\/10\/9\/1475\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T00:23:58Z","timestamp":1760142238000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-393X\/10\/9\/1475"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,6]]},"references-count":40,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2022,9]]}},"alternative-id":["vaccines10091475"],"URL":"https:\/\/doi.org\/10.3390\/vaccines10091475","relation":{},"ISSN":["2076-393X"],"issn-type":[{"value":"2076-393X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,6]]}}}